Literature DB >> 17418809

Inhibition of breast cancer cell adhesion and bone metastasis by the extracellular adherence protein of Staphylococcus aureus.

Darius Schneider1, Lucy Liaw, Carolin Daniel, Athanasios N Athanasopoulos, Mathias Herrmann, Klaus T Preissner, Peter P Nawroth, Triantafyllos Chavakis.   

Abstract

Bone metastasis is a common sequelae of breast cancer and the interaction of alpha v beta3-integrin with osteopontin (OPN) found in the extracellular matrix of mineralized tissues is implicated in this process. The integrin-dependent proadhesive and promigratory functions of OPN are particularly attributed to the 40 kD N-terminal fragment that derives upon matrix metalloproteinase (MMP) cleavage. Based on the broad repertoire of interactions between Staphylococcus aureus extracellular adherence protein (Eap) and host components, we here characterized Eap to specifically interact with recombinant full-length OPN and the 40 kD N-terminal MMP cleavage fragment, but not with the 32 kD or the 25 kD C-terminal fragments of OPN. Eap thereby prevented the OPN/alpha v beta3-integrin interaction, as well as the alpha v beta3-integrin-dependent adhesion of MDA-MB-231 breast cancer cells to full-length OPN or to the 40 kD fragment and the migration of these cells towards OPN. Furthermore, Eap treatment markedly impaired the development of osseous metastasis of human MDA-MB-231 cells in vivo. Taken together, Eap may represent an attractive novel treatment for the prevention of breast cancer bone metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17418809      PMCID: PMC1913187          DOI: 10.1016/j.bbrc.2007.03.143

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

1.  Identification of dual alpha 4beta1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin.

Authors:  K J Bayless; G E Davis
Journal:  J Biol Chem       Date:  2001-01-25       Impact factor: 5.157

2.  Involvement of chemokine receptors in breast cancer metastasis.

Authors:  A Müller; B Homey; H Soto; N Ge; D Catron; M E Buchanan; T McClanahan; E Murphy; W Yuan; S N Wagner; J L Barrera; A Mohar; E Verástegui; A Zlotnik
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

3.  Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).

Authors:  R Agnihotri; H C Crawford; H Haro; L M Matrisian; M C Havrda; L Liaw
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

Review 4.  The functional and clinical roles of osteopontin in cancer and metastasis.

Authors:  K A Furger; R K Menon; A B Tuck; V H Bramwell; A F Chambers
Journal:  Curr Mol Med       Date:  2001-11       Impact factor: 2.222

5.  Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes.

Authors:  Triantafyllos Chavakis; Muzaffar Hussain; Sandip M Kanse; Georg Peters; Reinhard G Bretzel; Jan-Ingmar Flock; Mathias Herrmann; Klaus T Preissner
Journal:  Nat Med       Date:  2002-06-24       Impact factor: 53.440

6.  Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression.

Authors:  M A Chellaiah; N Kizer; R Biswas; U Alvarez; J Strauss-Schoenberger; L Rifas; S R Rittling; D T Denhardt; K A Hruska
Journal:  Mol Biol Cell       Date:  2003-01       Impact factor: 4.138

7.  Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone.

Authors:  Isabelle Pécheur; Olivier Peyruchaud; Claire-Marie Serre; Julien Guglielmi; Carole Voland; Francois Bourre; Christiane Margue; Martine Cohen-Solal; Annie Buffet; Nelly Kieffer; Philippe Clézardin
Journal:  FASEB J       Date:  2002-06-21       Impact factor: 5.191

8.  Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells.

Authors:  Brunhilde Felding-Habermann; Emilia Fransvea; Timothy E O'Toole; Lisa Manzuk; Barbara Faha; Mary Hensler
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

9.  Correlation between extent of osteolytic damage and metastatic burden of human breast cancer metastasis in nude mice: real-time PCR quantitation.

Authors:  Angus M Tester; Julie A Sharp; Nirada Dhanesuan; Mark Waltham; Erik W Thompson
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

10.  Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.

Authors:  Philip S Rudland; Angela Platt-Higgins; Mohamed El-Tanani; Suzete De Silva Rudland; Roger Barraclough; John H R Winstanley; Rachel Howitt; Christopher R West
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

View more
  4 in total

Review 1.  Osteopontin: an effector and an effect of tumor metastasis.

Authors:  L A Shevde; S Das; D W Clark; R S Samant
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

2.  Brucine inhibits bone metastasis of breast cancer cells by suppressing Jagged1/Notch1 signaling pathways.

Authors:  Ke-Fei Hu; Xiang-Ying Kong; Mi-Cun Zhong; Hong-Ye Wan; Na Lin; Xiao-Hua Pei
Journal:  Chin J Integr Med       Date:  2016-12-29       Impact factor: 1.978

3.  More than one tandem repeat domain of the extracellular adherence protein of Staphylococcus aureus is required for aggregation, adherence, and host cell invasion but not for leukocyte activation.

Authors:  Muzaffar Hussain; Axana Haggar; Georg Peters; Gursharan S Chhatwal; Mathias Herrmann; Jan-Ingmar Flock; Bhanu Sinha
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

4.  Staphylococcus aureus-Derived Extracellular Vesicles Enhance the Efficacy of Endocrine Therapy in Breast Cancer Cells.

Authors:  Jeongshin An; Hyungju Kwon; Woosung Lim; Byung-In Moon
Journal:  J Clin Med       Date:  2022-04-05       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.